Press releases

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended December 31, 2013, at 8:00 a.m. U.S. Eastern Standard Time...

Dubai, UAE - 28 January 2014, Medtronic, Inc. (NYSE: MDT), the world's largest medical technology company, providing therapies to treat many conditions including cardiac and vascular diseases,...

MINNEAPOLIS -- Jan. 28, 2014 -- Continuing to expand the role of endovascular aortic repair, Medtronic, Inc. (NYSE: MDT) has received approval from the U.S. Food and Drug Administration (FDA) for...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that Charles J. Dockendorff, executive vice president and chief financial officer, has decided to retire...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 24, 2014-- Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of

MUMBAI, India--(BUSINESS WIRE)--Jan. 23, 2014-- Further developing its capabilities in a key emerging market, Covidien (NYSE:COV) has officially opened its first training and education center in...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 23, 2014-- Covidien plc. (NYSE: COV) does not infringe certain patents held by Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, according to a...

BOULDER, Colo.--(BUSINESS WIRE)--Jan. 22, 2014-- Expanding its industry-leading vessel and tissue sealing portfolio, Covidien (NYSE:COV) received U.S. Food and Drug Administration (FDA) 510(k)...

MINNEAPOLIS - January 22, 2014 - Medtronic, Inc. (NYSE: MDT), today announced that the Medtronic SureScan® pacing systems - the first and only pacing systems in the United States that have been...

MINNEAPOLIS - Jan. 22, 2014 - Medtronic, Inc. (NYSE: MDT) announced that the U.S. Supreme Court ruled 9-0 in favor of Medtronic that the burden of proving infringement rests with the party...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 21, 2014-- Covidien plc (NYSE: COV) today announced it will exit its OneShot™ Renal Denervation program. This voluntary action is primarily in response to...

MINNEAPOLIS - Jan. 17, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve® System for severe...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 16, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

MINNEAPOLIS - Jan. 15, 2014 - A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic (NYSE:MDT) CoreValve® System infringed on...

DUBLIN--(BUSINESS WIRE)--Jan. 15, 2014-- Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 13, 2014-- Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one...

MINNEAPOLIS - January 9, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that its U.S. pivotal trial in renal denervation for treatment-resistant hypertension, SYMPLICITY HTN-3, failed to meet...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 9, 2014-- Covidien plc (NYSE: COV), Lightstone Ventures and New Enterprise Associates (NEA) will jointly invest in a new company launched by The Foundry, a...

MINNEAPOLIS - Jan 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual J.P. Morgan Healthcare Conference on...

MINNEAPOLIS - Jan. 6, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first patient has been enrolled in the VICTORY AF clinical trial, a prospective, non-randomized, controlled study of...

MINNEAPOLIS - Jan. 06, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired TYRX, Inc., a privately held, New Jersey-based developer of implantable combination antibiotic drug...

Thomson Reuters ONE via COMTEX) --Medtronic's Second Randomized, Controlled Renal Denervation Clinical Trial in the U.S. Will Potentially Expand Access to the Symplicity(TM) Renal Denervation...